advertisement

---

9.2.1 Ocular hypertension (17)

Showing records 1 to 17

Display all abstracts in classification 9.2.1 Ocular hypertension

Search within classification 9.2.1 Ocular hypertension

---

66214 Glaucoma Suspect: Diagnosis and Management
Chang RT
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2016; 5: 32-37

---

65862 Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography
Zhang X
American Journal of Ophthalmology 2016; 163: 29-37

---

66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Hernández R
British Journal of Ophthalmology 2016; 100: 1263-1268

---

66214 Glaucoma Suspect: Diagnosis and Management
Singh K
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2016; 5: 32-37

---

66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Burr JM
British Journal of Ophthalmology 2016; 100: 1263-1268

---

65862 Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography
Loewen N
American Journal of Ophthalmology 2016; 163: 29-37

---

66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Vale L
British Journal of Ophthalmology 2016; 100: 1263-1268

---

65862 Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography
Tan O
American Journal of Ophthalmology 2016; 163: 29-37

---

66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Azuara-Blanco A
British Journal of Ophthalmology 2016; 100: 1263-1268

---

65862 Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography
Greenfield DS; Schuman JS
American Journal of Ophthalmology 2016; 163: 29-37

---

66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Cook JA; Banister K
British Journal of Ophthalmology 2016; 100: 1263-1268

---

65862 Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography
Varma R
American Journal of Ophthalmology 2016; 163: 29-37

---

66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Tuulonen A
British Journal of Ophthalmology 2016; 100: 1263-1268

---

65862 Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography
Huang D
American Journal of Ophthalmology 2016; 163: 29-37

---

66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Ryan M
British Journal of Ophthalmology 2016; 100: 1263-1268

---

65862 Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography

American Journal of Ophthalmology 2016; 163: 29-37

---

66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective

British Journal of Ophthalmology 2016; 100: 1263-1268

---

---